Nifty

:

12987.00

Sensex

:

44259.74

128.60 (1.00%)
431.64 (0.98%)

Login

Nifty
Sensex

:
:

12987.00
44259.74

128.60 (1.00%)
431.64 (0.98%)

Indoco Remedies Ltd.

Pharmaceuticals & Drugs - Global

Rating :

65/99

BSE: 532612 | NSE: INDOCO

Watchlist

NSE BSE

264.85

26-Nov-2020

Open
High
Low
Previous Close

267.00
274.00
264.25
264.90

Volume
Traded Value (lacs)
52 Week High
52 Week Low

89424
239.79
296.00
143.60

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

2,441.52
42.72
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

2,665.30
0.11%
3.39

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

8.68
1.88
2.03

EBITDA CAGR (%)

10 Years
5 Years
3 Years

5.98
-6.37
-1.69

PAT CAGR (%)

10 Years
5 Years
3 Years

-7.19
-21.70
-16.32

P:E (Median)

8 Years
5 Years
3 Years

30.43
30.87
33.91

P:BV (Average)

8 Years
5 Years
3 Years

3.60
3.38
2.84

EV:EBITDA (Average)

8 Years
5 Years
3 Years

16.35
17.14
18.36

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 327.65 291.97 12.22% 275.86 252.67 9.18% 272.02 252.02 7.94% 289.34 262.56 10.20%
Expenses 267.47 259.83 2.94% 227.00 229.92 -1.27% 238.68 223.47 6.81% 254.23 237.78 6.92%
EBITDA 60.18 32.14 87.24% 48.86 22.75 114.77% 33.34 28.55 16.78% 35.11 24.78 41.69%
EBIDTM 18.37% 11.01% 17.71% 9.00% -0.29% -0.29% 12.13% 9.44%
Other Income 0.52 0.58 -10.34% 0.26 0.64 -59.38% 0.49 4.94 -90.08% 0.72 0.57 26.32%
Interest 5.89 5.37 9.68% 5.75 6.12 -6.05% 7.83 4.63 69.11% 6.93 3.72 86.29%
Depreciation 18.57 18.04 2.94% 19.13 16.99 12.60% 18.20 19.46 -6.47% 17.58 17.73 -0.85%
PBT 36.24 9.31 289.26% 24.24 0.28 8,557.14% 7.80 9.40 -17.02% 11.32 3.90 190.26%
Tax 11.13 1.98 462.12% 7.01 -1.90 - 2.40 -2.23 - 1.98 -1.44 -
PAT 25.11 7.33 242.56% 17.23 2.18 690.37% 5.40 11.63 -53.57% 9.34 5.34 74.91%
PATM 7.66% 2.51% 6.25% 0.86% 2.87% 2.87% 3.23% 2.03%
EPS 2.72 0.80 240.00% 1.87 0.24 679.17% 0.59 1.26 -53.17% 1.01 0.58 74.14%

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 328.24 292.57 12.19% 275.86 252.68 9.17% 271.99 252.05 7.91% 289.35 262.64 10.17%
Expenses 267.52 259.94 2.92% 227.21 230.26 -1.32% 238.70 223.65 6.73% 254.48 237.92 6.96%
EBITDA 60.72 32.63 86.09% 48.65 22.42 116.99% 33.29 28.40 17.22% 34.87 24.72 41.06%
EBIDTM 18.50% 11.15% 17.64% 8.87% 14.01% 14.01% 12.05% 9.41%
Other Income 0.52 0.58 -10.34% 0.26 0.64 -59.38% 0.50 4.95 -89.90% 0.72 0.56 28.57%
Interest 5.89 5.37 9.68% 5.75 6.12 -6.05% 7.83 4.63 69.11% 6.93 3.73 85.79%
Depreciation 18.57 18.04 2.94% 19.13 16.99 12.60% 18.20 19.47 -6.52% 17.59 17.72 -0.73%
PBT 36.78 9.80 275.31% 24.03 -0.05 - 7.76 9.25 -16.11% 11.07 3.83 189.03%
Tax 11.13 1.99 459.30% 6.99 -1.90 - 2.40 -2.24 - 1.97 -1.44 -
PAT 25.65 7.81 228.43% 17.04 1.85 821.08% 5.36 11.49 -53.35% 9.10 5.27 72.68%
PATM 7.81% 2.67% 6.18% 0.73% 7.11% 7.11% 3.15% 2.01%
EPS 2.78 0.85 227.06% 1.85 0.20 825.00% 0.58 1.25 -53.60% 0.99 0.57 73.68%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 1,164.87 1,105.99 967.73 1,038.21 1,072.06 1,004.76 854.00 727.71 630.39 568.77 481.07 Net Sales Growth 9.97% 14.29% -6.79% -3.16% 6.70% 17.65% 17.35% 15.44% 10.83% 18.23% Cost Of Goods Sold 753.76 330.43 320.17 346.03 359.60 347.97 298.45 269.17 262.57 244.98 208.56 Gross Profit 411.11 775.57 647.56 692.18 712.46 656.79 555.55 458.55 367.81 323.79 272.51 GP Margin 35.29% 70.12% 66.92% 66.67% 66.46% 65.37% 65.05% 63.01% 58.35% 56.93% 56.65% Total Expenditure 987.38 985.01 891.03 906.73 917.40 836.83 688.80 609.86 537.93 484.19 413.39 Power & Fuel Cost - 34.75 28.49 26.62 23.12 21.72 20.39 18.26 16.37 18.48 17.29 % Of Sales - 3.14% 2.94% 2.56% 2.16% 2.16% 2.39% 2.51% 2.60% 3.25% 3.59% Employee Cost - 255.32 231.26 220.34 216.05 181.41 139.64 129.05 107.74 81.88 67.27 % Of Sales - 23.09% 23.90% 21.22% 20.15% 18.06% 16.35% 17.73% 17.09% 14.40% 13.98% Manufacturing Exp. - 114.61 106.86 101.47 96.11 84.80 52.60 39.66 34.30 30.98 27.12 % Of Sales - 10.36% 11.04% 9.77% 8.96% 8.44% 6.16% 5.45% 5.44% 5.45% 5.64% General & Admin Exp. - 128.33 110.90 109.03 116.21 102.31 90.21 83.30 66.58 57.12 51.09 % Of Sales - 11.60% 11.46% 10.50% 10.84% 10.18% 10.56% 11.45% 10.56% 10.04% 10.62% Selling & Distn. Exp. - 89.28 62.75 70.53 73.22 55.89 50.99 47.82 33.02 35.30 29.60 % Of Sales - 8.07% 6.48% 6.79% 6.83% 5.56% 5.97% 6.57% 5.24% 6.21% 6.15% Miscellaneous Exp. - 32.31 30.58 32.70 33.09 42.73 36.51 22.60 17.36 15.45 29.60 % Of Sales - 2.92% 3.16% 3.15% 3.09% 4.25% 4.28% 3.11% 2.75% 2.72% 2.59% EBITDA 177.49 120.98 76.70 131.48 154.66 167.93 165.20 117.85 92.46 84.58 67.68 EBITDA Margin 15.24% 10.94% 7.93% 12.66% 14.43% 16.71% 19.34% 16.19% 14.67% 14.87% 14.07% Other Income 1.99 4.79 6.71 8.15 6.10 4.14 1.74 3.96 1.50 2.26 5.89 Interest 26.40 26.25 21.09 23.51 6.16 12.15 10.34 18.80 21.87 16.33 3.53 Depreciation 73.48 70.81 71.56 67.71 63.27 60.63 47.11 30.91 23.72 19.25 13.45 PBT 79.60 28.71 -9.24 48.43 91.34 99.29 109.48 72.11 48.37 51.27 56.58 Tax 22.52 4.46 -6.40 7.23 13.88 17.00 26.67 14.21 5.71 4.92 5.47 Tax Rate 28.29% 15.53% 69.26% 14.93% 15.20% 17.12% 24.36% 19.71% 11.80% 9.60% 9.67% PAT 57.08 24.25 -2.84 41.20 77.46 82.29 82.81 57.90 42.66 46.34 51.12 PAT before Minority Interest 57.08 24.25 -2.84 41.20 77.46 82.29 82.81 57.90 42.66 46.34 51.12 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 4.90% 2.19% -0.29% 3.97% 7.23% 8.19% 9.70% 7.96% 6.77% 8.15% 10.63% PAT Growth 115.56% - - -46.81% -5.87% -0.63% 43.02% 35.72% -7.94% -9.35% EPS 6.19 2.63 -0.31 4.47 8.40 8.93 8.98 6.28 4.63 5.03 5.54

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Jun 06 Jun 05
Net Sales 1,165.44 1,106.58 968.45 1,041.94 1,074.77 1,008.12 857.32 732.61 630.79 243.43 194.15 Net Sales Growth 9.95% 14.26% -7.05% -3.05% 6.61% 17.59% 17.02% 16.14% 159.13% 25.38% Cost Of Goods Sold 4,898.74 330.43 320.25 347.83 361.27 350.01 300.44 271.98 262.57 104.32 81.04 Gross Profit -3,733.30 776.15 648.19 694.11 713.49 658.12 556.87 460.63 368.22 139.10 113.10 GP Margin -320.33% 70.14% 66.93% 66.62% 66.39% 65.28% 64.95% 62.88% 58.37% 57.14% 58.25% Total Expenditure 987.91 985.74 891.80 910.37 920.27 840.17 691.81 614.44 538.15 198.37 154.21 Power & Fuel Cost - 34.75 28.49 26.62 23.12 21.72 20.39 18.26 16.37 7.32 4.17 % Of Sales - 3.14% 2.94% 2.55% 2.15% 2.15% 2.38% 2.49% 2.60% 3.01% 2.15% Employee Cost - 256.51 231.66 220.91 216.67 181.87 140.04 129.54 107.87 25.71 20.09 % Of Sales - 23.18% 23.92% 21.20% 20.16% 18.04% 16.33% 17.68% 17.10% 10.56% 10.35% Manufacturing Exp. - 114.63 107.07 101.94 96.38 85.18 52.92 40.58 34.30 14.25 9.22 % Of Sales - 10.36% 11.06% 9.78% 8.97% 8.45% 6.17% 5.54% 5.44% 5.85% 4.75% General & Admin Exp. - 127.76 110.92 110.04 116.40 102.56 90.39 83.49 66.64 25.10 22.56 % Of Sales - 11.55% 11.45% 10.56% 10.83% 10.17% 10.54% 11.40% 10.56% 10.31% 11.62% Selling & Distn. Exp. - 89.28 62.75 70.53 73.22 55.89 51.00 47.83 33.02 15.97 12.76 % Of Sales - 8.07% 6.48% 6.77% 6.81% 5.54% 5.95% 6.53% 5.23% 6.56% 6.57% Miscellaneous Exp. - 32.38 30.66 32.49 33.20 42.94 36.63 22.75 17.38 5.70 12.76 % Of Sales - 2.93% 3.17% 3.12% 3.09% 4.26% 4.27% 3.11% 2.76% 2.34% 2.25% EBITDA 177.53 120.84 76.65 131.57 154.50 167.95 165.51 118.17 92.64 45.06 39.94 EBITDA Margin 15.23% 10.92% 7.91% 12.63% 14.38% 16.66% 19.31% 16.13% 14.69% 18.51% 20.57% Other Income 2.00 4.80 6.70 8.05 5.93 4.03 1.71 3.97 1.50 10.02 4.81 Interest 26.40 26.25 21.09 23.51 6.21 12.39 10.58 18.92 21.87 5.79 3.75 Depreciation 73.49 70.82 71.57 67.71 63.28 60.66 47.09 30.90 23.72 6.32 4.34 PBT 79.64 28.57 -9.31 48.40 90.94 98.93 109.55 72.32 48.55 42.96 36.65 Tax 22.49 4.45 -6.41 7.24 13.87 16.99 26.73 14.28 5.79 11.47 11.61 Tax Rate 28.24% 15.58% 68.85% 14.96% 15.25% 17.17% 24.40% 19.75% 11.93% 26.70% 31.68% PAT 57.15 24.12 -2.90 41.16 77.06 81.94 82.81 57.98 42.72 31.49 25.04 PAT before Minority Interest 57.15 24.12 -2.90 41.16 77.06 81.94 82.81 58.03 42.76 31.49 25.04 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.05 -0.04 0.00 0.00 PAT Margin 4.90% 2.18% -0.30% 3.95% 7.17% 8.13% 9.66% 7.91% 6.77% 12.94% 12.90% PAT Growth 116.31% - - -46.59% -5.96% -1.05% 42.83% 35.72% 35.66% 25.76% EPS 6.20 2.62 -0.31 4.46 8.36 8.89 8.98 6.29 4.63 3.42 2.72

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 680.16 661.08 675.56 651.88 576.45 518.38 456.97 414.04 379.95 350.20 Share Capital 18.43 18.43 18.43 18.43 18.43 18.43 18.43 18.43 12.29 12.29 Total Reserves 661.73 642.65 657.13 633.45 558.02 499.95 438.54 395.61 367.66 337.91 Non-Current Liabilities 100.91 116.34 125.27 146.97 66.33 64.58 69.84 78.22 89.33 92.10 Secured Loans 96.93 128.66 123.28 132.31 34.24 9.42 7.20 21.41 46.24 54.05 Unsecured Loans 0.00 0.00 0.00 0.00 3.64 3.44 6.59 5.97 0.00 0.00 Long Term Provisions 27.08 15.91 23.74 30.87 40.72 15.03 16.34 6.82 4.56 3.50 Current Liabilities 459.17 445.33 416.89 390.37 301.77 258.58 199.28 197.08 182.27 120.92 Trade Payables 166.29 170.70 149.44 164.17 131.01 118.63 69.14 68.09 76.45 46.61 Other Current Liabilities 135.35 117.02 119.32 72.07 57.30 40.88 53.88 51.32 50.03 37.46 Short Term Borrowings 105.98 113.39 109.93 118.36 86.47 73.06 56.60 62.84 41.46 22.77 Short Term Provisions 51.55 44.21 38.19 35.77 26.99 26.02 19.66 14.84 14.33 14.07 Total Liabilities 1,240.24 1,222.75 1,217.72 1,189.22 944.55 841.54 726.09 689.34 651.55 563.22 Net Block 589.62 467.52 488.73 439.75 373.26 339.41 325.28 321.43 301.62 212.62 Gross Block 1,126.60 934.50 884.96 769.49 641.58 547.28 481.41 446.94 403.58 295.88 Accumulated Depreciation 536.99 466.98 396.23 329.74 268.32 207.87 156.14 125.51 101.96 83.27 Non Current Assets 678.48 686.25 680.57 619.04 483.08 460.11 424.88 416.45 389.55 337.40 Capital Work in Progress 50.70 185.43 135.56 90.63 54.80 62.71 44.12 37.78 32.61 52.70 Non Current Investment 2.45 2.44 2.61 2.82 2.61 0.64 0.45 0.40 0.12 0.02 Long Term Loans & Adv. 26.07 21.75 33.58 66.34 48.02 57.13 54.80 56.52 54.90 68.61 Other Non Current Assets 9.64 9.11 20.09 19.51 4.39 0.21 0.25 0.31 0.30 3.45 Current Assets 561.76 536.50 537.15 570.18 461.46 381.43 301.20 272.90 262.01 225.82 Current Investments 0.00 0.00 0.00 0.00 15.68 0.00 0.00 0.00 0.00 0.00 Inventories 208.24 183.37 193.23 185.04 164.47 146.20 108.26 92.76 101.89 80.42 Sundry Debtors 209.18 194.47 207.83 215.73 187.72 153.64 137.25 127.08 113.71 91.79 Cash & Bank 37.65 36.18 11.81 62.40 12.44 15.28 13.14 11.81 10.48 23.80 Other Current Assets 106.70 15.54 6.45 17.63 81.15 66.31 42.55 41.25 35.93 29.81 Short Term Loans & Adv. 97.59 106.94 117.83 89.38 72.50 61.98 38.41 35.29 33.41 27.50 Net Current Assets 102.59 91.17 120.27 179.81 159.70 122.85 101.92 75.82 79.74 104.90 Total Assets 1,240.24 1,222.75 1,217.72 1,189.22 944.54 841.54 726.08 689.35 651.56 563.22

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Jun 06 Jun 05
Shareholder's Funds 679.57 660.62 674.98 651.34 576.52 518.80 457.15 414.17 198.38 175.31 Share Capital 18.43 18.43 18.43 18.43 18.43 18.43 18.43 18.43 11.82 11.82 Total Reserves 661.14 642.19 656.55 632.91 558.08 500.37 438.72 395.74 186.56 163.49 Non-Current Liabilities 101.00 116.42 125.34 147.04 66.28 64.65 69.87 78.22 53.79 59.52 Secured Loans 96.93 128.66 123.28 132.31 34.24 9.42 7.20 21.41 26.45 30.37 Unsecured Loans 0.00 0.00 0.00 0.00 3.64 3.44 6.59 5.97 9.81 19.39 Long Term Provisions 27.14 15.95 23.77 30.91 40.63 15.04 16.36 6.82 0.00 0.00 Current Liabilities 458.99 445.50 417.36 390.39 302.95 262.12 202.15 199.28 58.53 50.09 Trade Payables 165.60 170.72 149.55 164.03 131.31 119.86 70.66 68.26 41.06 34.19 Other Current Liabilities 135.81 117.13 119.66 72.16 57.38 40.97 53.98 51.34 7.40 7.32 Short Term Borrowings 105.98 113.39 109.93 118.36 87.23 75.38 57.96 64.84 0.00 0.00 Short Term Provisions 51.59 44.26 38.22 35.84 27.03 25.92 19.54 14.84 10.07 8.58 Total Liabilities 1,239.56 1,222.54 1,217.68 1,188.77 945.75 845.57 729.42 691.87 310.70 284.92 Net Block 589.74 467.65 488.86 439.89 373.64 339.80 325.43 321.55 138.99 83.28 Gross Block 1,126.76 934.65 885.11 769.65 641.95 547.64 481.56 447.06 165.56 103.94 Accumulated Depreciation 537.02 467.00 396.25 329.75 268.32 207.84 156.13 125.51 26.57 20.65 Non Current Assets 676.45 684.49 678.73 616.72 481.20 460.22 424.85 416.36 143.54 96.15 Capital Work in Progress 50.70 185.43 135.56 90.63 54.80 62.71 44.12 37.78 4.55 12.86 Non Current Investment 0.02 0.02 0.02 0.02 0.02 0.17 0.17 0.12 0.00 0.00 Long Term Loans & Adv. 26.16 22.01 33.92 66.46 48.15 57.31 54.88 56.59 0.00 0.00 Other Non Current Assets 9.83 9.38 20.36 19.72 4.60 0.22 0.25 0.31 0.00 0.00 Current Assets 563.10 538.05 538.96 572.05 464.55 385.36 304.56 275.51 166.28 187.37 Current Investments 0.00 0.00 0.00 0.00 15.68 0.00 0.00 0.00 6.33 40.07 Inventories 208.32 183.45 193.38 186.94 166.69 149.12 110.22 93.18 35.60 30.11 Sundry Debtors 210.14 195.84 209.51 215.68 188.83 155.38 138.13 127.08 83.41 74.07 Cash & Bank 37.93 36.26 11.90 62.59 12.63 15.40 13.39 13.99 25.20 28.58 Other Current Assets 106.71 15.55 6.46 17.64 80.72 65.46 42.83 41.25 15.73 14.54 Short Term Loans & Adv. 97.60 106.96 117.71 89.21 72.06 61.13 38.68 35.29 15.73 14.54 Net Current Assets 104.12 92.55 121.60 181.66 161.60 123.23 102.41 76.23 107.75 137.28 Total Assets 1,239.55 1,222.54 1,217.69 1,188.77 945.75 845.58 729.41 691.87 310.70 284.92

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 122.66 132.13 122.76 87.81 112.31 109.91 99.94 68.86 69.07 37.81 PBT 28.71 -9.24 48.43 91.34 99.29 109.48 72.11 48.37 51.27 56.58 Adjustment 99.51 89.34 97.82 64.31 78.78 64.96 50.27 47.14 33.07 10.99 Changes in Working Capital -1.65 55.66 -13.59 -44.07 -38.46 -39.86 -7.84 -18.32 -5.27 -17.92 Cash after chg. in Working capital 126.57 135.75 132.65 111.57 139.61 134.58 114.54 77.19 79.07 49.65 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -3.92 -3.62 -9.89 -23.77 -27.31 -24.68 -14.60 -8.33 -10.00 -11.84 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -55.95 -103.76 -135.43 -170.54 -112.62 -88.39 -40.93 -42.89 -63.86 -76.91 Net Fixed Assets -57.37 -99.41 -160.40 -163.74 -86.39 -84.46 -40.81 -48.53 -87.61 -50.46 Net Investments -0.01 0.17 0.21 15.47 -17.65 -0.19 -0.05 -0.28 -0.10 0.00 Others 1.43 -4.52 24.76 -22.27 -8.58 -3.74 -0.07 5.92 23.85 -26.45 Cash from Financing Activity -63.95 -16.14 -38.77 132.40 0.17 -20.63 -58.23 -26.41 -17.44 24.40 Net Cash Inflow / Outflow 2.76 12.23 -51.44 49.67 -0.15 0.89 0.78 -0.44 -12.23 -14.70 Opening Cash & Equivalents 20.72 8.48 59.92 10.25 10.40 9.52 8.74 9.18 21.41 36.11 Closing Cash & Equivalent 23.48 20.72 8.48 59.92 10.25 10.40 9.52 8.74 9.18 21.41

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Jun 06 Jun 05
Cash From Operating Activity 122.85 132.11 122.72 88.64 113.34 109.04 98.81 68.69 36.99 6.11 PBT 28.57 -9.31 48.40 90.94 100.58 109.55 72.32 48.55 42.96 36.65 Adjustment 99.51 89.35 97.67 64.60 76.29 65.21 50.38 47.14 6.77 4.11 Changes in Working Capital -1.49 55.62 -13.23 -43.25 -36.12 -41.01 -9.16 -18.57 -5.99 -26.02 Cash after chg. in Working capital 126.60 135.66 132.83 112.29 140.75 133.75 113.53 77.12 43.73 14.74 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -3.75 -3.55 -10.12 -23.65 -27.41 -24.71 -14.72 -8.43 -6.74 -8.63 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -55.93 -103.76 -135.43 -170.55 -111.96 -88.41 -40.98 -42.61 -15.75 -89.60 Net Fixed Assets -57.37 -99.41 -160.40 -163.74 -86.39 -84.46 -40.81 -349.01 -29.62 Net Investments -0.01 0.17 0.21 15.47 -17.65 -0.19 -0.05 11.09 33.74 Others 1.45 -4.52 24.76 -22.28 -7.92 -3.76 -0.12 295.31 -19.87 Cash from Financing Activity -63.95 -16.14 -38.77 131.57 -1.48 -19.92 -58.98 -24.41 -24.61 94.50 Net Cash Inflow / Outflow 2.97 12.22 -51.48 49.66 -0.11 0.70 -1.15 1.67 -3.38 11.01 Opening Cash & Equivalents 20.80 8.58 60.06 10.40 10.47 9.77 10.92 9.25 28.58 17.57 Closing Cash & Equivalent 23.76 20.80 8.58 60.06 10.36 10.47 9.77 10.92 25.20 28.58

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 73.81 71.74 73.31 70.74 62.55 56.25 49.59 44.93 41.23 38.00 ROA 1.97% -0.23% 3.42% 7.26% 9.21% 10.57% 8.18% 6.36% 7.63% 9.81% ROE 3.62% -0.43% 6.21% 12.61% 15.03% 16.98% 13.29% 10.75% 12.69% 15.47% ROCE 5.79% 1.24% 7.61% 11.84% 16.78% 20.66% 16.83% 13.68% 14.33% 14.55% Fixed Asset Turnover 1.07 1.06 1.26 1.55 1.69 1.68 1.60 1.51 1.65 1.73 Receivable days 66.60 75.87 74.21 67.30 62.00 61.36 65.15 68.49 65.09 68.51 Inventory Days 64.62 71.02 66.28 58.30 56.43 53.67 49.55 55.36 57.74 56.14 Payable days 68.05 71.94 66.81 61.95 56.43 51.50 43.27 52.71 30.79 20.33 Cash Conversion Cycle 63.17 74.95 73.68 63.66 62.01 63.53 71.42 71.15 92.03 104.31 Total Debt/Equity 0.38 0.45 0.42 0.43 0.24 0.18 0.20 0.29 0.30 0.28 Interest Cover 2.09 0.56 3.06 15.83 9.17 11.59 4.84 3.21 4.14 17.03

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Jun 06 Jun 05
Book Value (Rs.) 73.75 71.69 73.25 70.68 62.56 56.30 49.61 44.94 22.28 19.62 ROA 1.96% -0.24% 3.42% 7.22% 9.15% 10.52% 8.17% 8.53% 10.57% 8.79% ROE 3.60% -0.43% 6.21% 12.55% 14.96% 16.97% 13.32% 13.98% 16.96% 14.40% ROCE 5.78% 1.23% 7.62% 11.80% 16.72% 20.63% 16.84% 18.33% 21.31% 18.06% Fixed Asset Turnover 1.07 1.06 1.26 1.55 1.69 1.69 1.61 2.10 2.00 2.08 Receivable days 66.96 76.39 74.23 67.31 62.31 61.67 64.94 59.83 106.60 125.29 Inventory Days 64.61 71.01 66.40 58.84 57.17 54.49 49.80 36.61 44.48 50.93 Payable days 67.82 71.91 66.57 61.79 56.58 52.08 43.51 39.89 77.53 93.34 Cash Conversion Cycle 63.74 75.49 74.06 64.37 62.91 64.09 71.24 56.55 73.55 82.88 Total Debt/Equity 0.39 0.45 0.42 0.43 0.24 0.19 0.20 0.29 0.18 0.29 Interest Cover 2.09 0.56 3.06 15.64 8.98 11.35 4.82 3.22 8.41 10.77

Top Investors:

reliance capital trustee co ltd a/c nippon india small cap fund

icici prudential pharma healthcare & diaganostic

sundaram mutual fund a/c sundaram small cap

mangeshi investment private limited

Annual Reports:

News Update:

Indoco Remedies launches Favipiravir 400 mg tablets in India
28th Sep 2020, 09:00 AM

Fevindo 400 reduces pill burden by 50% and ensures convenient dosing and better patient compliance
Read More
Indoco Remedies gets USFDA’s nod for Apixaban Tablets
14th Sep 2020, 10:34 AM

It is used for patients with health problems caused by a blood clot
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback